This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Risperidone-Carbamazepine Interactions: Is Cytochrome P450 3A Involved?

Hsien-Yuan Lane and Wen-Ho Chang

Published: August 15, 1998

Article Abstract

Sir: De Leon and Bork recently highlighted potential pharmacokinetic interactions between risperidone and carbamazepine. They presented a patient in whom carbamazepine coadministration lowered plasma levels of risperidone greater than 2-fold. Earlier, Ereshefsky indicated that carbamazepine can induce the activities of cytochrome P450 3A (CYP3A) and possibly CYP2B. Accordingly, de Leon and Bork1 further suggested that risperidone metabolism, which is known to involve CYP2D6, also involves CYP3A.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 59

Quick Links: Dementia , Neurologic and Neurocognitive

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...